Ovulation Triggering 2 vs 3 Follicles - Trial NCT06290921
Access comprehensive clinical trial information for NCT06290921 through Pure Global AI's free database. This phase not specified trial is sponsored by Clinique Ovo and is currently Recruitment Completed. The study focuses on Infertility. Target enrollment is 400 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Clinique Ovo
Timeline & Enrollment
N/A
Feb 22, 2024
Feb 20, 2025
Primary Outcome
Clinical Pregnancy Rate
Summary
Poor responders in in-vitro fertilization (IVF) cycles represent a major challenge for
 fertility specialists. Although poor responders tend to have sub-optimal fertility treatment
 outcomes, many of these patients wish to attempt at least one IVF cycle. Traditionally, IVF
 cycles producing less than 3 to 4 mature follicles (measuring at least 14 mm) have either
 been cancelled or converted to intra-uterine insemination (IUI) due to the low pregnancy
 rates associated with these cycles. The minimal number of follicles required to proceed with
 egg collection is based on clinical experience, having been determined by weighing the
 probability of implantation and pregnancy versus the risk of not obtaining quality oocytes or
 reaching embryo transfer when fewer mature follicles are present. This retrospective quality
 control study aims to compare pregnancy rates in IVF cycles producing 3 follicles measuring
 14 mm and more on trigger day, versus 2 or fewer follicles.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06290921
Non-Device Trial